Impaired Plasmalogens in Patients with Schizophrenia

R: A Language and Environment for Statistical Computing

R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,706 · see citing works

A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES

Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189 · see citing works

Statistical significance for genomewide studies

Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692 · see citing works

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892 · see citing works

Rethinking schizophrenia

Insel, T. R. (2010) · Nature · doi:10.1038/nature09552 · Cited by 1,783 · see citing works

Metabolomics: A Global Biochemical Approach to Drug Response and Disease

Kaddurah-Daouk, R. F., Kristal, B. S., & Weinshilboum, R. M. (2008) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094715 · Cited by 669 · see citing works

Progressive Structural Brain Abnormalities and Their Relationship to Clinical Outcome

Ho, B., Andreasen, N. C., Nopoulos, P., Arndt, S. V., Magnotta, V. A., & Flaum, M. A. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.585 · Cited by 536 · see citing works

Lipid Rafts Are Enriched in Arachidonic Acid and Plasmenylethanolamine and Their Composition Is Independent of Caveolin-1 Expression: A Quantitative Electrospray Ionization/Mass Spectrometric Analysis

PIKE, L. J., Han, X., Chung, K.-N., & Gross, R. W. (2002) · Biochemistry · doi:10.1021/bi0156557 · Cited by 512 · see citing works

The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia

Horrobin, D. F. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00151-5 · Cited by 456 · see citing works

Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview

Mazza, M., Pomponi, M., Janiri, L., Bria, P., & Mazza, S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.07.010 · Cited by 306 · see citing works

Calcium ions in neuronal degeneration

Wojda, U., Salińska, E., & Kuźnicki, J. (2008) · IUBMB Life · doi:10.1002/iub.91 · Cited by 298 · see citing works

Brain Membrane Phospholipid Alterations in Alzheimer's Disease

Pettegrew, J. W., Panchalingam, K., Hamilton, R. L., & McClure, R. J. (2001) · Neurochemical Research · doi:10.1023/a:1011603916962 · Cited by 292 · see citing works

Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients

Yao, J. K., Leonard, S. S., & Reddy, R. D. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00095-x · Cited by 290 · see citing works

Metabolomics: A Global Biochemical Approach to the Study of Central Nervous System Diseases

Kaddurah-Daouk, R. F., & Krishnan, K. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.174 · Cited by 289 · see citing works

Lipid metabolome-wide effects of the PPARγ agonist rosiglitazone

Watkins, S. M., Reifsnyder, P. C., Pan, H.-J., German, J. B., & Leiter, E. H. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200169-jlr200 · Cited by 274 · see citing works

Metabolomic Mapping of Atypical Antipsychotic Effects in Schizophrenia

Kaddurah-Daouk, R., McEvoy, J., Baillie, R. A., Lee, D., Yao, J. K., Doraiswamy, P. M., & Krishnan, K. R. R. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002000 · Cited by 262 · see citing works

Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia

Goodenowe, D. B., Cook, L. L., Liu, J., Lu, Y., Jayasinghe, D., Ahiahonu, P. W. K., Heath, D., Yamazaki, Y., Flax, J., Krenitsky, K. F., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.p700023-jlr200 · Cited by 253 · see citing works

Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain

Ginsberg, L., Rafique, S., Xuereb, J. H., Rapoport, S. I., & Gershfeld, N. L. (1995) · Brain Research · doi:10.1016/0006-8993(95)00931-f · Cited by 248 · see citing works

Fatty acid levels in the brains of schizophrenics and normal controls

Horrobin, D. F., Manku, M. S., Hillman, H., IAIN, A., & Glen, M. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90235-e · Cited by 240 · see citing works

Book Review: Plasmalogens: Workhorse Lipids of Membranes in Normal and Injured Neurons and Glia

Farooqui, A. A., & Horrocks, L. A. (2001) · The Neuroscientist · doi:10.1177/107385840100700308 · Cited by 237 · see citing works

Oxidative stress and role of antioxidant and ω-3 essential fatty acid supplementation in schizophrenia

Mahadik, S. P., Evans, D. R., & Lal, H. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00181-0 · Cited by 229 · see citing works

High Throughput Lipidomic Profiling of Schizophrenia and Bipolar Disorder Brain Tissue Reveals Alterations of Free Fatty Acids, Phosphatidylcholines, and Ceramides

Schwarz, E., Prabakaran, S., Whitfield, P. D., Major, H. J., Leweke, F. M., Koethe, D., McKenna, P. J., & Bahn, S. (2008) · Journal of Proteome Research · doi:10.1021/pr800188y · Cited by 222 · see citing works

Plasmalogens in Biological Systems: Their Role in Oxidative Processes in Biological Membranes, their Contribution to Pathological Processes and Aging and Plasmalogen Analysis

Leßig, J., & Fuchs, B. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788682164 · Cited by 220 · see citing works

Alzheimer’s disease: the lipid connection

Hartmann, T., Kuchenbecker, J., & Grimm, M. O. W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04715.x · Cited by 199 · see citing works

Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment

Kaddurah-Daouk, R., Baillie, R. A., Zhu, H., Zeng, Z.-B., Wiest, M. M., Nguyen, U. T., Wojnoonski, K., Watkins, S. M., Trupp, M., & Krauss, R. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025482 · Cited by 193 · see citing works

Identification of plasmalogen as the major phospholipid constituent of cardiac sarcoplasmic reticulum

Gross, R. W. (1985) · Biochemistry · doi:10.1021/bi00328a014 · Cited by 187 · see citing works

Is the high propensity of ethanolamine plasmalogens to form non-lamellar lipid structures manifested in the properties of biomembranes?

Lohner, K. (1996) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(96)02580-7 · Cited by 186 · see citing works

Lipid Alterations in the Earliest Clinically Recognizable Stage of Alzheimers Disease: Implication of the Role of Lipids in the Pathogenesis of Alzheimers Disease

Han, X. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772786 · Cited by 183 · see citing works

Reduced Red Blood Cell Membrane Essential Polyunsaturated Fatty Acids in First Episode Schizophrenia at Neuroleptic-Naive Baseline

Reddy, R. D., Keshavan, M. S., & Yao, J. K. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007140 · Cited by 161 · see citing works

Glycine and a Glycine Dehydrogenase (GLDC) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics-Informed Pharmacogenomics

Ji, Y., Hebbring, S. J., Zhu, H., Jenkins, G. D., Biernacka, J. M., Snyder, K., Drews, M., Fiehn, O., Zeng, Z., Schaid, D. J., et al. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.250 · Cited by 160 · see citing works

Effects of sample handling and storage on quantitative lipid analysis in human serum

Zivkovic, A. M., Wiest, M. M., Nguyen, U. T., Davis, R., Watkins, S. M., & German, J. B. (2009) · Metabolomics · doi:10.1007/s11306-009-0174-2 · Cited by 154 · see citing works

The semistructured BPRS interview and rating guide.

Rhoades, H. M., & Overall, J. E. (1988) · PubMed · Cited by 142 · see citing works

The American Psychiatric Publishing Textbook of Schizophrenia

(2007) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e318033a46f · Cited by 138 · see citing works

No evidence for astrogliosis in brains of schizophrenic patients. A post‐mortem study

Falkai, P., Honer, David, Bogerts, Majtenyi, & Bayer (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00162.x · Cited by 132 · see citing works

Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder

Hibbeln, J. R., Makino, K. K., Martin, C. E., Dickerson, F., Boronow, J. J., & Fenton, W. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01549-4 · Cited by 126 · see citing works

Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders

Martínez, M., Méndez, E. V., García‐Silva, M. T., Manzanares, J., Bertran, J. M., Castelló, F., & Mougan, I. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.1.376s · Cited by 122 · see citing works

The biological significance of plasmalogens in defense against oxidative damage

Brosche, T., & Platt, D. (1998) · Experimental Gerontology · doi:10.1016/s0531-5565(98)00014-x · Cited by 119 · see citing works

Metabolic Profiling Reveals Distinct Variations Linked to Nicotine Consumption in Humans — First Results from the KORA Study

Wang‐Sattler, R., Yu, Y., Mittelstraß, K., Lattka, E., Altmaier, E., Gieger, C., Ladwig, K., Dahmen, N., Weinberger, K. M., Hao, P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003863 · Cited by 118 · see citing works

Plasmalogen synthesis is regulated via alkyl‐dihydroxyacetonephosphate‐synthase by amyloid precursor protein processing and is affected in Alzheimer’s disease

Grimm, M. O. W., Kuchenbecker, J., Rothhaar, T. L., Grösgen, S., Hundsdörfer, B., Burg, V. K., Frieß, P., Müller, U., Grimm, H. S., Riemenschneider, M. J., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07070.x · Cited by 115 · see citing works

Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport

Munn, N. J., Arnio, E., Liu, D., Zoeller, R. A., & Liscum, L. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200363-jlr200 · Cited by 115 · see citing works

31P Nuclear Magnetic Resonance Spectroscopy: Neurodevelopment and Schizophrenia

Pettegrew, J. W., Keshavan, M. S., & Minshew, N. J. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.1.35 · Cited by 115 · see citing works

Erythrocyte membrane phospholipids in psychotic patients

Keshavan, M. S., Mallinger, A. G., Pettegrew, J. W., & Dippold, C. S. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90032-c · Cited by 95 · see citing works

Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study.

Cheng, H., Xu, J., McKeel, D. W., & Han, X. (2003) · PubMed · Cited by 90 · see citing works

A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients

Stenvinkel, P. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.10.2594 · Cited by 86 · see citing works

Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease

Perry, G. L., Lee, H., Lee, H. P., Zhu, X., Smith, M. A., Rolston, R. K., Marlatt, M. W., Castellani, R. J., Nunomura, A., Casadesús, G., et al. (2010) · International Journal of Biomedical Science · doi:10.59566/ijbs.2010.6225 · Cited by 81 · see citing works

Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy

Stenvinkel, P., Diczfalusy, U., Lindholm, B., & Heimbürger, O. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh035 · Cited by 67 · see citing works

Plasmalogen status influences docosahexaenoic acid levels in a macrophage cell line: insights using ether lipid-deficient variants

Gaposchkin, D. P., & Zoeller, R. A. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32454-8 · Cited by 58 · see citing works

High-Performance Liquid Chromatography Separations Coupled With Coulometric Electrode Array Detectors

Kristal, B. S., Shurubor, Y. I., Kaddurah-Daouk, R. F., & Matson, W. R. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-244-1_10 · Cited by 56 · see citing works

Effect of aging on plasma membrane fluidity of rat aortic endothelial cells☆

Hashimoto, M., Hossain, S., & Masumura, S. (1999) · Experimental Gerontology · doi:10.1016/s0531-5565(99)00025-x · Cited by 56 · see citing works

Signaling events mediating activation of brain ethanolamine plasmalogen hydrolysis by ceramide

Latorre, E., Collado, M. P., Fernández, I., Aragonés, M. D., & Catalán, R. E. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03356.x · Cited by 45 · see citing works

Maternal smoking habits are associated with differences in infants' long-chain polyunsaturated fatty acids in whole blood: a case-control study

Agostoni, C. V., Riva, E., Giovannini, M., Pinto, F., Colombo, C., Risé, P., Galli, C. L., & Marangoni, F. (2008) · Archives of Disease in Childhood · doi:10.1136/adc.2007.129817 · Cited by 37 · see citing works

Effects of aging and dietary n−3 fatty acids on rat brain phospholipids: Focus on plasmalogens

André, A., Juanéda, P., Sébédio, J. L., & Chardigny, J. (2005) · Lipids · doi:10.1007/s11745-005-1441-x · Cited by 34 · see citing works

Nonesterified Fatty Acids Induce Transmembrane Monovalent Cation Flux: Host−Guest Interactions as Determinants of Fatty Acid-Induced Ion Transport

Zeng, Y., Han, X., Schlesinger, P. H., & Gross, R. W. (1998) · Biochemistry · doi:10.1021/bi980303u · Cited by 34 · see citing works

Ethanolamine plasmalogen and cholesterol reduce the total membrane oxidizability measured by the oxygen uptake method

Maeba, R., & Ueta, N. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00157-8 · Cited by 34 · see citing works

Membrane fatty acid levels as a predictor of treatment response in chronic schizophrenia

Sumiyoshi, T., Higuchi, Y., Matsui, M., Itoh, H., Uehara, T., Itoh, T., Arai, H., Takamiya, C., Suzuki, M., & Kurachi, M. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.07.049 · Cited by 31 · see citing works

Phospholipid Subclass-Specific Alterations in the Kinetics of Ion Transport across Biologic Membranes

Chen, X., & Gross, R. W. (1994) · Biochemistry · doi:10.1021/bi00250a030 · Cited by 28 · see citing works

Environmental factors and membrane polyunsaturated fatty acids in schizophrenia

Reddy, R. D., & Yao, J. K. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.08.009 · Cited by 27 · see citing works

Role of calcium regulation in pathophysiology model of schizophrenia and possible interventions

Yarlagadda, A. (2002) · Medical Hypotheses · doi:10.1054/mehy.2001.1511 · Cited by 27 · see citing works

Abnormal transbilayer distribution of phospholipids in red blood cell membranes in schizophrenia

Nuss, P., Tessier, C., Ferreri, F., Binder, M. D., Peuskens, J., Trugnan, G., Masliah, J., & Wolf, C. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2009.01.009 · Cited by 26 · see citing works

Degradation of specific polyunsaturated fatty acids in red blood cells stored at −20°C proceeds faster in patients with schizophrenia when compared with healthy controls

Fox, H. C., Ross, B. M., Tocher, D. R., Horrobin, D. F., Glen, I., & Clair, D. S. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(03)00084-x · Cited by 24 · see citing works

Gender-specific fatty acid profiles in platelet phosphatidyl-choline and -ethanolamine

Geppert, J., Min, Y., Neville, M., Lowy, C., & Ghebremeskel, K. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.09.002 · Cited by 22 · see citing works

A novel antioxidant action of ethanolamine plasmalogens in lowering the oxidizability of membranes

Maeba, R., & Ueta, N. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320141 · Cited by 21 · see citing works

Reversible reduction of phospholipid bound arachidonic acid after low density lipoprotein apheresis. Evidence for rapid incorporation of plasmalogen phosphatidylethanolamine into the red blood cell membrane

Engelmann, B., Bräutigam, C., Kulschar, R., Duhm, J., Prenner, E. J., Hermetter, A., Richter, W. O., Thiery, J., & Seidel, D. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)00227-4 · Cited by 19 · see citing works

Decreased plasmalogen concentration as a surrogate marker of oxidative stress in patients presenting with acute coronary syndromes or supraventricular tachycardias

Brosche, T., Brueckmann, M., Haase, K. K., Sieber, C. C., & Bertsch, T. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.111 · Cited by 17 · see citing works

Effects of aging on the relation of adenyl purine release with plasma membrane fluidity of arterial endothelial cells

Hashimoto, M., Hossain, S., Tanabe, Y., & Shido, O. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.07.007 · Cited by 10 · see citing works

Comparative Roles of Phospholipase A2Isoforms in Cardiovascular Pathophysiology

McHowat, J., & Creer, M. H. (2001) · Cardiovascular Toxicology · doi:10.1385/ct:1:4:253 · Cited by 9 · see citing works

Serum plasmalogens in ischemic cerebrovascular disease.

Hoerrmann, W., Donis, J., Sluga, E., Stütz, H., & Paltauf, F. (1991) · PubMed · Cited by 9 · see citing works

Analytical Methods in Lipidomics and Their Applications

Li, M., Li, Y., Bai, Y., & Liu, H. (2013) · Analytical Chemistry · doi:10.1021/ac403554h · Cited by 210 · see citing works

Peroxisomes in brain development and function

Berger, J., Dorninger, F., Forss-Petter, S., & Kunze, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.005 · Cited by 194 · see citing works

From peroxisomal disorders to common neurodegenerative diseases – the role of ether phospholipids in the nervous system

Dorninger, F., Forss‐Petter, S., & Berger, J. (2017) · FEBS Letters · doi:10.1002/1873-3468.12788 · Cited by 162 · see citing works

Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy

Naviaux, J. C., Schuchbauer, M. A., Li, K., Wang, L., Risbrough, V. B., Powell, S. B., & Naviaux, R. K. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.33 · Cited by 134 · see citing works

Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics

McEvoy, J., Baillie, R. A., Zhu, H., Buckley, P., Keshavan, M. S., Nasrallah, H. A., Dougherty, G. G., Yao, J. K., & Kaddurah-Daouk, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068717 · Cited by 127 · see citing works

EPT1 (selenoprotein I) is critical for the neural development and maintenance of plasmalogen in humans

Horibata, Y., Elpeleg, O. N., Eran, A., Hirabayashi, Y., Savitzki, D., Tal, G., Mandel, H., & Sugimoto, H. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p081620 · Cited by 115 · see citing works

Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations

Tessier, C., Sweers, K., Frajerman, A., Bergaoui, H., Ferreri, F., Delva, C., Lapidus, N., Lamazière, A., Roiser, J. P., Hert, M. A. F. D., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.142 · Cited by 101 · see citing works

Changes in Plasma Lipids during Exposure to Total Sleep Deprivation

Chua, E. C.-P., Shui, G., Cazenave‐Gassiot, A., Wenk, M. R., & Gooley, J. J. (2015) · SLEEP · doi:10.5665/sleep.5142 · Cited by 100 · see citing works

Homeostasis of phospholipids — The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens

Dorninger, F., Brodde, A., Braverman, N., Moser, A. B., Just, W. W., Forss‐Petter, S., Brügger, B., & Berger, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.11.005 · Cited by 96 · see citing works

Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study

Solberg, D. K., Bentsen, H., Refsum, H., & Andreassen, O. A. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1006-3 · Cited by 82 · see citing works

Lipid Alteration Signature in the Blood Plasma of Individuals With Schizophrenia, Depression, and Bipolar Disorder

Tkachev, A., Stekolshchikova, E., Vanyushkina, A., Zhang, H., Morozova, A. Y., Zozulya, S. A., Kurochkin, I., Anikanov, N. A., Egorova, A., Yushina, E., et al. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.4350 · Cited by 78 · see citing works

MS/MS analysis and imaging of lipids across Drosophila brain using secondary ion mass spectrometry

Phan, N. T. N., Munem, M., Ewing, A. G., & Fletcher, J. S. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-017-0336-4 · Cited by 55 · see citing works

Profiling of Lipidomics Before and After Antipsychotic Treatment in First-Episode Psychosis

Leppik, L., Parksepp, M., Janno, S., Koido, K., Haring, L., Vasar, E., & Zilmer, M. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0971-6 · Cited by 55 · see citing works

Regulation of plasmalogen metabolism and traffic in mammals: The fog begins to lift

Dorninger, F., Werner, E. R., Berger, J., & Watschinger, K. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.946393 · Cited by 54 · see citing works

Antipsychotics Promote Metabolic Disorders Disrupting Cellular Lipid Metabolism and Trafficking

Vantaggiato, C., Panzeri, E., Citterio, A., Orso, G., & Pozzi, M. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.01.003 · Cited by 53 · see citing works

Intact lipid imaging of mouse brain samples: MALDI, nanoparticle-laser desorption ionization, and 40 keV argon cluster secondary ion mass spectrometry

Mohammadi, A. S., Phan, N. T. N., Fletcher, J. S., & Ewing, A. G. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9812-5 · Cited by 51 · see citing works

Biological Functions of Plasmalogens

Hossain, M. S., Mawatari, S., & Fujino, T. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-60204-8_13 · Cited by 50 · see citing works

Dysfunctional plasmalogen dynamics in the plasma and platelets of patients with schizophrenia

Wood, P. L., Unfried, G., Whitehead, W. F., Phillipps, A., & Wood, J. A. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.11.032 · Cited by 50 · see citing works

Impaired Metabolic Reactivity to Oxidative Stress in Early Psychosis Patients

Fournier, M., Ferrari, C., Baumann, P. S., Polari, A., Monin, A., Bellier-Teichmann, T., Wulff, J., Pappan, K. L., Cuenod, M., Conus, P., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu053 · Cited by 48 · see citing works

Schizophrenia biomarkers: Translating the descriptive into the diagnostic

Pickard, B. S. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114566631 · Cited by 48 · see citing works

Association between serum lipids and membrane fatty acids and clinical characteristics in patients with schizophrenia

Solberg, D. K., Bentsen, H., Refsum, H., & Andreassen, O. A. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12388 · Cited by 47 · see citing works

Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders

Sethi, S., Hayashi, M. A. F., Sussulini, A., Tasić, L., & Brietzke, E. M. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1117656 · Cited by 44 · see citing works

Identification of a plasma signature of psychotic disorder in children and adolescents from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort

O’Gorman, A., Suvitaival, T., Ahonen, L. L., Cannon, M. D., Zammit, S., Lewis, G., Roche, H. M., Mattila, I. M., Hyötyläinen, T., Orešič, M., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.211 · Cited by 44 · see citing works

Oral administration of a synthetic vinyl-ether plasmalogen normalizes open field activity in a mouse model of rhizomelic chondrodysplasia punctata

Fallatah, W., Smith, T. M., Cui, W., Jayasinghe, D., Pietro, E. D., Ritchie, S. A., & Braverman, N. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.042499 · Cited by 43 · see citing works

Plasmalogen Replacement Therapy

Bozelli, J. C., & Epand, R. M. (2021) · Membranes · doi:10.3390/membranes11110838 · Cited by 42 · see citing works

Lipid Structural Effects of Oral Administration of Methylphenidate inDrosophilaBrain by Secondary Ion Mass Spectrometry Imaging

Phan, N. T. N., Fletcher, J. S., & Ewing, A. G. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00555 · Cited by 40 · see citing works

Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis

Gjerde, P. B., Dieset, I., Simonsen, C., Hoseth, E. Z., Iversen, T., Lagerberg, T. V., Lyngstad, S. H., Mørch, R. H., Skrede, S., Andreassen, O. A., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.10.042 · Cited by 40 · see citing works

Chronic inflammation, neuroglial dysfunction, and plasmalogen deficiency as a new pathobiological hypothesis addressing the overlap between post-COVID-19 symptoms and myalgic encephalomyelitis/chronic fatigue syndrome

Filho, A. J. M. C., Braniff, O., Angelova, A., Deng, Y., & Tremblay, M. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110702 · Cited by 39 · see citing works

Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers

Zorkina, Y., Ushakova, V., Ochneva, A., Tsurina, A., Abramova, O., Savenkova, V., Goncharova, A., Alekseenko, I., Morozova, I., Riabinina, D., et al. (2024) · Metabolites · doi:10.3390/metabo14020080 · Cited by 36 · see citing works

Gene‐specific DNA methylation may mediate atypical antipsychotic‐induced insulin resistance

Burghardt, K. J., Goodrich, J. M., Dolinoy, D. C., & Ellingrod, V. L. (2016) · Bipolar Disorders · doi:10.1111/bdi.12422 · Cited by 36 · see citing works

Lipidomic profiling of tryptophan hydroxylase 2 knockout mice reveals novel lipid biomarkers associated with serotonin deficiency

Weng, R., Shen, S., Burton, C., Yang, L., Nie, H., Tian, Y., Bai, Y., & Liu, H. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-9256-3 · Cited by 31 · see citing works

Translational bioinformatics in mental health: open access data sources and computational biomarker discovery

Tenenbaum, J. D., Bhuvaneshwar, K., Gagliardi, J. P., Hollis, K. F., Jia, P., Ma, L., Nagarajan, R., Rakesh, G., Subbian, V., Visweswaran, S., et al. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx157 · Cited by 30 · see citing works

Roles of endogenous ether lipids and associated PUFAs in the regulation of ion channels and their relevance for disease

Fontaine, D., Figiel, S., Félix, R., Kouba, S., Fromont, G., Mahéo, K., Potier‐Cartereau, M., Chantôme, A., & Vandier, C. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000634 · Cited by 30 · see citing works

Lipidomics, Biomarkers, and Schizophrenia: A Current Perspective

Sethi, S., Hayashi, M. A. F., Correia, B. S. B., Pontes, J. G. D. M., Tasić, L., & Brietzke, E. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-47656-8_11 · Cited by 29 · see citing works

Therapeutic Efficacy of Plasmalogens for Alzheimer’s Disease, Mild Cognitive Impairment, and Parkinson’s Disease in Conjunction with a New Hypothesis for the Etiology of Alzheimer’s Disease

Fujino, T., Hossain, M. S., & Mawatari, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-60204-8_14 · Cited by 29 · see citing works

Unbiased Metabolite Profiling of Schizophrenia Fibroblasts under Stressful Perturbations Reveals Dysregulation of Plasmalogens and Phosphatidylcholines

Huang, J., Park, H., Iaconelli, J., Berkovitch, S. S., Watmuff, B., McPhie, D. L., Öngür, D., Cohen, B. M., Clish, C. B., & Karmacharya, R. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00628 · Cited by 28 · see citing works

HPLC-Based Mass Spectrometry Characterizes the Phospholipid Alterations in Ether-Linked Lipid Deficiency Models Following Oxidative Stress

Drechsler, R., Chen, S.-W., Dancy, B. C. R., Mehrabkhani, L., & Olsen, C. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167229 · Cited by 28 · see citing works

Characterising Phospholipids and Free Fatty Acids in Patients with Schizophrenia: A Case-Control Study

Wang, D., Sun, X., Maziade, M., Mao, W., Zhang, C., Wang, J., & Cao, B. (2021) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1769188 · Cited by 26 · see citing works

Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis

Kanagasundaram, P., Lee, J., Prasad, F., Costa-Dookhan, K. A., Hamel, L., Gordon, M., Remington, G. J., Hahn, M., & Agarwal, S. M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.642403 · Cited by 26 · see citing works

Shift in phospholipid and fatty acid contents accompanies brain myelination

Naffaa, V., Magny, R., Regazzetti, A., Steenwinckel, J. V., Gressèns, P., Laprévôte, O., Auzeil, N., & Schang, A. (2022) · Biochimie · doi:10.1016/j.biochi.2022.08.010 · Cited by 26 · see citing works

Measurement of Ether Phospholipids in Human Plasma with HPLC–ELSD and LC/ESI–MS After Hydrolysis of Plasma with Phospholipase A1

Mawatari, S., Hazeyama, S., & Fujino, T. (2016) · Lipids · doi:10.1007/s11745-016-4170-9 · Cited by 22 · see citing works

Metabolomics-based understanding of the olanzapine-induced weight gain in female first-episode drug-naïve patients with schizophrenia

Liu, J. H., Chen, N., Guo, Y. H., Guan, X. N., Wang, J., Wang, D., & Xiu, M. H. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.06.001 · Cited by 21 · see citing works

Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia

Liu, J., Xiu, M., Liu, H., Wang, J., & Li, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.735196 · Cited by 19 · see citing works

The synaptic lipidome in health and disease

Vallés, A. S., & Barrantes, F. J. (2022) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2022.184033 · Cited by 16 · see citing works

Bifunctional Probes Reveal the Rules of Intracellular Ether Lipid Transport

Böhlig, K., Iglesias‐Artola, J. M., Asaro, A., Lennartz, H. M., Link, A. C., Drobot, B., & Nadler, A. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202513360 · Cited by 14 · see citing works

Dietary Lipid Intervention in the Prevention of Brain Aging

Xiong, W., Fang, B., Wang, X., Zhang, M., Du, M., Sun, J., Chen, J., Li, Y., Sun, C., Lei, X. G., et al. (2023) · Engineering · doi:10.1016/j.eng.2023.04.012 · Cited by 14 · see citing works

Diabetes adversely affects phospholipid profiles in human carotid artery endarterectomy plaques

Zayed, M. A., Hsu, F., Patterson, B. W., Yan, Y., Naim, U., Darwesh, M., Silva, G. D., Yang, C. Y., & Semenkovich, C. F. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m081026 · Cited by 14 · see citing works

Association between olanzapine treatment and brain cortical thickness and gray/white matter contrast is moderated by cholesterol in psychotic disorders

Gjerde, P. B., Jørgensen, K. N., Steen, N. E., Melle, I. S., Andreassen, O. A., Steen, V. M., & Agartz, I. (2018) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2018.10.001 · Cited by 12 · see citing works

Shorter Chain Triglycerides Are Negatively Associated with Symptom Improvement in Schizophrenia

Tkachev, A., Stekolshchikova, E., Anikanov, N., Zozulya, S., Barkhatova, A., Klyushnik, T., & Petrova, D. (2021) · Biomolecules · doi:10.3390/biom11050720 · Cited by 11 · see citing works

Lipidomic analysis of p ‐chlorophenylalanine‐treated mice using continuous‐flow two‐dimensional liquid chromatography/quadrupole time‐of‐flight mass spectrometry

Weng, R., Shen, S., Li, Y., Li, M., Tian, Y., Bai, Y., & Liu, H. (2015) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.7241 · Cited by 11 · see citing works

Altered lipidomics biosignatures in schizophrenia: A systematic review

Messinis, A., Panteli, E., Paraskevopoulou, A., Zymarikopoulou, A.-K., & Filiou, M. D. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.06.043 · Cited by 10 · see citing works

Peripheral Lipid Signatures, Metabolic Dysfunction, and Pathophysiology in Schizophrenia Spectrum Disorders

Wu, S., Panganiban, K. J., Lee, J., Li, D., Smith, E. C. C., Maksyutynska, K., Humber, B. E., Ahmed, T., Agarwal, S. M., Ward, K. M., et al. (2024) · Metabolites · doi:10.3390/metabo14090475 · Cited by 11 · see citing works

Sex-Specific Effect of Serum Lipids and Body Mass Index on Psychotic Symptoms, a Cross-Sectional Study of First-Episode Psychosis Patients

Gjerde, P. B., Simonsen, C., Lagerberg, T. V., Steen, N. E., Andreassen, O. A., Steen, V. M., & Melle, I. S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.723158 · Cited by 10 · see citing works

Psychotic relapse prediction via biomarker monitoring: a systematic review

Smyrnis, A., Theleritis, C. G., Ferentinos, P. P., & Smyrnis, N. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1463974 · Cited by 9 · see citing works

First‐In‐Human Safety, Tolerability, and Pharmacokinetics of PPI ‐1011, a Synthetic Plasmalogen Precursor

Smith, T. M., Knudsen, K. J., & Ritchie, S. A. (2025) · Clinical and Translational Science · doi:10.1111/cts.70195 · Cited by 8 · see citing works

Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia

Tkachev, A., Stekolshchikova, E., Morozova, A. Y., Anikanov, N. A., Zorkina, Y., Alekseyeva, P. N., Khobta, E. B., Andreyuk, D., Zozulya, S. A., Barkhatova, A., et al. (2021) · Consortium Psychiatricum · doi:10.17816/cp101 · Cited by 8 · see citing works

Liquid Chromatography Coupled to Mass Spectrometry-Based Metabolomics and the Concept of Biomarker

Boudah, S., Paris, A., & Junot, C. (2013) · Advances in botanical research · doi:10.1016/b978-0-12-397922-3.00004-6 · Cited by 8 · see citing works

Atypical Antipsychotics and the Human Skeletal Muscle Lipidome

Burghardt, K. J., Ward, K. M., Sanders, E., Howlett, B. H., Seyoum, B., & Yi, Z. (2018) · Metabolites · doi:10.3390/metabo8040064 · Cited by 8 · see citing works

Lipid‐correlated alterations in the transcriptome are enriched in several specific pathways in the postmortem prefrontal cortex of Japanese patients with schizophrenia

Arihisa, W., Kondo, T., Yamaguchi, K., Matsumoto, J., Nakanishi, H., Kunii, Y., Akatsu, H., Hino, M., Hashizume, Y., Sato, S., et al. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12368 · Cited by 7 · see citing works

Impact of a Standard Rodent Chow Diet on Tissue n‐6 Fatty Acids, Δ9‐Desaturation Index, and Plasmalogen Mass in Rats Fed for One Year

Pédrono, F., Boulier‐Monthéan, N., Catheline, D., & Legrand, P. (2015) · Lipids · doi:10.1007/s11745-015-4068-y · Cited by 7 · see citing works

Familial risk for bipolar disorder is not associated with impaired peroxisomal function: Dissociation from docosahexaenoic acid deficits

McNamara, R. K., Moser, A. B., Jones, R. I., Jandacek, R. J., Patino, L. R., Strawn, J. R., Strakowski, S. M., & DelBello, M. P. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.10.042 · Cited by 7 · see citing works

Investigating the association of the plasma lipidomic profile with cognitive performance and genetic risk in the PsyCourse study

Kohshour, M. O., Papiol, S., Tkachev, A., Stekolshchikova, E., Adorjan, K., Budde, M., Heilbronner, U., Heilbronner, M., Kalman, J., Reich-Erkelenz, D., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03323-5 · Cited by 4 · see citing works

Alterations to sphingolipid metabolism from antipsychotic administration in healthy volunteers are restored following the use of cannabidiol

Jieu, B., Sykorova, E. B., Rohleder, C., Marcolini, E., Hoffmann, A., Koethe, D., Leweke, F. M., & Couttas, T. A. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116005 · Cited by 6 · see citing works

A novel inducible animal model for studying chronic plasmalogen deficiency associated with Alzheimer’s disease

Smith, T. M., Knudsen, K. J., & Ritchie, S. A. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149132 · Cited by 7 · see citing works

Enzymatic measurement of ether phospholipids in human plasma after hydrolysis of plasma with phospholipase A1

Mawatari, S., Hazeyama, S., Morisaki, T., & Fujino, T. (2018) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2018.01.003 · Cited by 6 · see citing works

Identifying serum lipidomic signatures related to prognosis in first-episode schizophrenia

Luo, M., Zhang, S., Xue, J., Gao, T., Li, X., Zhai, Z., Lu, C., Dong, Y., Zhuo, K., Xiang, Q., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06802-7 · Cited by 5 · see citing works

LC–HRMS Lipidomic Fingerprints in Serbian Cohort of Schizophrenia Patients

Marković, S., Jadranin, M. B., Miladinović, Z. P., Gavrilović, A., Avramović, N., Takić, M. M., Tasić, L., Tešević, V., & Mandić, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910266 · Cited by 4 · see citing works

Plasma and Serum LC-MS Lipidomic Fingerprints of Bipolar Disorder and Schizophrenia

Takić, M. M., Jovanović, V. B., Marković, S., Miladinović, Z. P., Jadranin, M. B., Krstić, G., Miljević, Č., Tešević, V., & Mandić, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136134 · Cited by 4 · see citing works

Impact of life adversity and gene expression on psychiatric symptoms in children and adolescents: findings from the Brazilian high risk cohort study

Ota, V., de Oliveira, A. M., Bugiga, A., Conceição, H. B., Galante, P. A. F., Asprino, P. F., Schäfer, J., Hoffmann, M. S., Bressan, R. A., Brietzke, E. M., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1505421 · Cited by 4 · see citing works

Prospects for the diagnosis and treatment of plasmalogen deficiency

Polyakova, S. I., Zasurtsev, G. V., Parshina, P. V., & Kobrinskiy, B. A. (2021) · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) · doi:10.21508/1027-4065-2021-66-4-16-24 · Cited by 4 · see citing works

Lipidomics

Benedusi, V. (2018) · Materials and Methods · doi:10.13070/mm.en.8.2665 · Cited by 4 · see citing works

Metabolomics of Schizophrenia

Rujescu, D., & Giegling, I. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801829-3.00018-5 · Cited by 4 · see citing works

Mass spectrometry imaging of two neocortical areas reveals the histological selectivity of schizophrenia-associated lipid alterations

Osetrova, M., Zavolskova, M., Mazin, P., Stekolshchikova, E., Vladimirov, G., Efimova, O., Morozova, A. Y., Zorkina, Y., Andreyuk, D., Kostyuk, G. P., et al. (2024) · Consortium Psychiatricum · doi:10.17816/cp15488 · Cited by 3 · see citing works

Cognitive improvements linked to lysophosphatidylethanolamine after olanzapine treatment in drug-naïve first-episode schizophrenia

Li, J., Xu, Y., Wang, X., Liu, C., Li, Z., Xiu, M., & Chen, H. (2024) · Metabolomics · doi:10.1007/s11306-024-02171-6 · Cited by 2 · see citing works

Dysregulation of SELENOI Is Associated with TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis

Isik, F. I., Galper, J., Pickford, R., Dzamko, N. L., Fu, Y., & Kim, W. S. (2025) · Cells · doi:10.3390/cells14181457 · Cited by 2 · see citing works

Mass spectrometry based analysis of drugs, neurotransmitters and lipids in invertebrate model systems

Phan, N. T. N. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University)

Metabolomics to Study Psychotic Disorders and Their Metabolic Comorbidities

Orešič, M. (2014) · Advances in biological psychiatry · doi:10.1159/000358032

Atypical Antipsychotics and Dyslipidemia- Experience at Psychiatry Hospital Hyderabad, Pakistan.

Khuhro, Q., Channa, N. A., Amur, S. A., Para, M., Mugheri, M. H., & Soomro, N. A. (2018) · Annals of King Edward Medical University · doi:10.21649/akemu.v24is.2504

The association of change in serum cholesterol levels and clinical treatment response in patients with schizophrenia: a prospective, randomized and open-label studyPreprint

Chen, Y.-L., Chiu, C., Chen, K., Tai, M., & Lung, F. (2019) · doi:10.21203/rs.2.12759/v1

Multiomics Approaches in Psychiatric Disorders

Schulte, E. C., Kohshour, M. O., Tkachev, A., Khaitovich, P., & Schulze, T. G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_30-1

Multiomics Approaches in Psychiatric Disorders

Schulte, E. C., Kohshour, M. O., Tkachev, A., Khaitovich, P., & Schulze, T. G. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_30

A polyunsaturated fatty acid (PUFA) theory of schizophrenia

Rappoport, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-44-345008-2.00009-6

Mechanistische Analyse des intrazellulären Transports von Etherlipiden mittels bifunktioneller Sonden

Böhlig, K., Iglesias‐Artola, J. M., Asaro, A., Lennartz, H. M., Link, A. C., Drobot, B., & Nadler, A. (2025) · Angewandte Chemie · doi:10.1002/ange.202513360

Lysophosphatidylethanolamine correlated with cognitive improvements after treatment with olanzapine in drug-naïve first-episode schizophrenia: a prospective cohort studyPreprint

Su, L., Xiu, M., Guan, X., & Wu, F. (2022) · Research Square · doi:10.21203/rs.3.rs-2339101/v1

Causal association between lipid profile and mental disorders: evidence from a bidirectional Mendelian randomization study

Hu, W.-S., Wu, Y., & Li, P. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-02191-w

Neuronal lipidome in schizophrenia and metabolic syndrome: Potential interventions

Sfera, A., Turturica, E., Turturica, D., Ciuperca, I., Ikhimiukor, D., Anton, J., Bozza, B., & Nicolson, G. L. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111647

Plasma Lipid Alterations Track Multidimensional Psychosis Severity Across Diagnostic BoundariesPreprint

Thanabalasingam, A., Wiegand, A., Meijer, J., Dwyer, D., Schulte, E. C., & Study, T. P. (2026) · medRxiv · doi:10.64898/2026.02.24.26346956

L'interaction entre le canal calcique Orai3 et la protéine réticulaire STIM2 contribue à la prolifération et la survie des cellules cancéreuses prostatiques

Kouba, S. (2020) · theses.fr (ABES) · doi:10.70675/5b5af316z8676z4980zaa53zd235bf449fcb

Antipsychotics Chlorpromazine and Clozapine Inhibit Membrane Fusion Through Direct Interaction with Lipid BilayersPreprint

Fumat, H., Adrien, V., Nola, S., Niort, K., Galli, T., Nuss, P., & Tareste, D. C. (2026) · Research Square · doi:10.21203/rs.3.rs-10446355/v1

Dysfunctional plasmalogen dynamics in the plasma and platelets of patients with schizophrenia

Wood, P. L., Unfried, G., Whitehead, W. F., Phillipps, A., & Wood, J. A. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.11.032 · Cited by 50 · see citing works

Plasma membrane phospholipid and cholesterol distribution of skin fibroblasts from drug-naive patients at the onset of psychosis

Mahadik, S. P., Mukherjee, S., Correnti, E. E., Kelkar, H. S., Wakade, C. G., Costa, R. M., & Scheffer, R. E. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90048-5 · Cited by 82 · see citing works

Temporal lobe structure angulation in first-episode schizophrenia

Wu, H., Bilder, R. M., & Lieberman, J. A. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(96)84017-0

Increased platelet membrane lysophosphatidylcholine in schizophrenia

Pangerl, A. M., Steudle, A., Jaroni, H. W., Rufer, R., & Gattaz, W. F. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90239-i · Cited by 58 · see citing works

Progressive membrane phospholipid changes in first episode schizophrenia with high field magnetic resonance spectroscopy

Miller, J., Drost, D. J., Jensen, E., Manchanda, R., Northcott, S., Neufeld, R. W. J., Menon, R. S., Rajakumar, N., Pavlosky, W. F., Densmore, M., et al. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.06.017 · Cited by 23 · see citing works